Axion Capital Management, LLC


Axion Capital Management is asset management firm offering alternative investment opportunities and wealth management services to institutions and high net worth individuals.

Our hedge fund, Axion Opportunity Fund, LP. has consistently ranked at or near the top of the equity opportunistic long/short and Global Macro classifications. In 2009, and 2010, Axion Opportunity Fund, LP was ranked #1 in class for compound annual return by Barclay Hedge in the 3 year and 5 year intervals, as well as over the life of the Fund.

Axion Capital Management also has extensive experience in the private equity space. Over the years our firm has funded unique opportunities in technology and life sciences. Most recently, we were the lead investor in AmpliMed Corporation, a biotech drug discovery company founded by renowned oncologists, which currently has multiple drugs in late stage clinical trials.